Regarding large genetic lesions involving ASXL1 mutation in MDS, some studies have proposed -7/7q deletion as a secondary event to ASXL1 mutation, which can cause activation of the RTK-RAS pathway, promoting leukemic transformation [74,76]. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.